0000899243-23-009095.txt : 20230320 0000899243-23-009095.hdr.sgml : 20230320 20230320160517 ACCESSION NUMBER: 0000899243-23-009095 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230316 FILED AS OF DATE: 20230320 DATE AS OF CHANGE: 20230320 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bachleda Mark CENTRAL INDEX KEY: 0001887762 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39114 FILM NUMBER: 23746416 MAIL ADDRESS: STREET 1: C/O GALERA THERAPEUTICS, INC. STREET 2: 2 W LIBERTY BOULEVARD, #110 CITY: MALVERN STATE: PA ZIP: 19355 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Galera Therapeutics, Inc. CENTRAL INDEX KEY: 0001563577 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 461454898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: P.O. BOX 134 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 610-725-1500 MAIL ADDRESS: STREET 1: P.O. BOX 134 CITY: MALVERN STATE: PA ZIP: 19355 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-03-16 0 0001563577 Galera Therapeutics, Inc. GRTX 0001887762 Bachleda Mark C/O GALERA THERAPEUTICS, INC. P.O. BOX 134 MALVERN PA 19355 0 1 0 0 Chief Commercial Officer 0 Common Stock 2023-03-16 4 P 0 11000 2.247 A 11000 D The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.21 to $2.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. /s/ Chris Degnan, Attorney-in-Fact for Mark Bachleda 2023-03-20